During the ramp-up phase, while production quantities are relatively limited, the Company is targeting end-product applications in fashion and performance apparel. "Because production quantities will be relatively limited during the early stages of the production ramp-up, and because we will have control of that limited supply of
As production quantities increase, the Company expects to begin addressing demand from additional market segments, including:
- Engineering textiles
- Composites
- Cosmetics
- Defensive and protective textiles
- Bio-plastics that are biodegradable and bio-compatible
- Fiber optics
- Medical textiles, fibers, ligaments, wound dressings, skin grafts, and tissue engineering
The Company believes that the enhanced strength and toughness of its
To view the most recent news from
About
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
(720) 288-8495
ir@KraigLabs.com
Source:
2024 GlobeNewswire, Inc., source